These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34059085)

  • 1. The "Intermediate" CD14 + CD16 + monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki disease.
    Kim YS; Yang HJ; Kee SJ; Choi I; Ha K; Ki KK; Jeong IS; Cho HJ
    Pediatr Rheumatol Online J; 2021 May; 19(1):76. PubMed ID: 34059085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease.
    Choi IS; Lee MJ; Choi SA; Choi KS; Jeong IS; Cho HJ
    Front Pediatr; 2021; 9():792870. PubMed ID: 35186822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.
    Ichiyama T; Ueno Y; Hasegawa M; Ishikawa Y; Matsubara T; Furukawa S
    Rheumatology (Oxford); 2005 Mar; 44(3):314-7. PubMed ID: 15572393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD14+CD16+ monocyte subpopulation in Kawasaki disease.
    Katayama K; Matsubara T; Fujiwara M; Koga M; Furukawa S
    Clin Exp Immunol; 2000 Sep; 121(3):566-70. PubMed ID: 10971526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions.
    Xia Y; Tian X; Li Q; Wang G; Li C; Yang J
    Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease.
    Matsuguma C; Wakiguchi H; Suzuki Y; Okada S; Furuta T; Ohnishi Y; Azuma Y; Ohga S; Hasegawa S
    Scand J Rheumatol; 2019 Nov; 48(6):491-496. PubMed ID: 31272272
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immunoglobulin does not increase FcγRIIB expression levels on monocytes in children with immune thrombocytopenia.
    Shimomura M; Hasegawa S; Seki Y; Fukano R; Hotta N; Ichiyama T
    Clin Exp Immunol; 2012 Jul; 169(1):33-7. PubMed ID: 22670776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease.
    Abe J; Jibiki T; Noma S; Nakajima T; Saito H; Terai M
    J Immunol; 2005 May; 174(9):5837-45. PubMed ID: 15843588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
    Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium.
    Suzuki A; Fukuzawa K; Yamashita T; Yoshida A; Sasaki N; Emoto T; Takei A; Fujiwara R; Nakanishi T; Yamashita S; Matsumoto A; Konishi H; Ichibori H; Hirata KI
    Europace; 2017 Jan; 19(1):40-47. PubMed ID: 26826137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
    Abeles RD; McPhail MJ; Sowter D; Antoniades CG; Vergis N; Vijay GK; Xystrakis E; Khamri W; Shawcross DL; Ma Y; Wendon JA; Vergani D
    Cytometry A; 2012 Oct; 81(10):823-34. PubMed ID: 22837127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
    Ye Q; Gong FQ; Shang SQ; Hu J
    Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte platelet aggregates in children with Kawasaki disease- a preliminary study from a tertiary care centre in North-West India.
    Vignesh P; Rawat A; Shandilya JK; Singh Sachdeva MU; Ahluwalia J; Singh S
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):25. PubMed ID: 33712020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of circulating monocytes at baseline and after activation in patients with intracranial aneurysm.
    Wang J; Cao Y
    Hum Immunol; 2020 Jan; 81(1):41-47. PubMed ID: 31735443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C
    Pediatr Rheumatol Online J; 2019 Nov; 17(1):78. PubMed ID: 31775782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of increased expression of activating Fc receptors and novel findings regarding distinct IgE and IgM receptors in Kawasaki disease.
    Chang LS; Ming-Huey Guo M; Lo MH; Kuo HC
    Pediatr Res; 2021 Jan; 89(1):191-197. PubMed ID: 31816620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin inhibits NF-kappaB activation and affects Fcgamma receptor expression in monocytes/macrophages.
    Ichiyama T; Ueno Y; Hasegawa M; Niimi A; Matsubara T; Furukawa S
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):428-33. PubMed ID: 14985941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
    Iwashima S; Kimura M; Ishikawa T; Ohzeki T
    Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.